← Back to Search
Protein Nanoparticles For Therapeutic Protein Delivery.
L. Herrera Estrada, J. Champion
Published 2015 · Medicine, Biology
Download PDFAnalyze on Scholarcy
Therapeutic proteins can face substantial challenges to their activity, requiring protein modification or use of a delivery vehicle. Nanoparticles can significantly enhance delivery of encapsulated cargo, but traditional small molecule carriers have some limitations in their use for protein delivery. Nanoparticles made from protein have been proposed as alternative carriers and have benefits specific to therapeutic protein delivery. This review describes protein nanoparticles made by self-assembly, including protein cages, protein polymers, and charged or amphipathic peptides, and by desolvation. It presents particle fabrication and delivery characterization for a variety of therapeutic and model proteins, as well as comparison of the features of different protein nanoparticles.
This paper references
Protein therapeutics: a summary and pharmacological classification
B. Leader (2008)
Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.
K. Langer (2008)
Pharmacokinetics and bone formation by BMP-2 entrapped in polyethylenimine-coated albumin nanoparticles.
S. Zhang (2009)
Cell death induced by the herpes simplex virus-1 thymidine kinase delivered by human immunodeficiency virus-1-based virus-like particles.
Silvia Peretti (2005)
Elastic protein-based polymers in soft tissue augmentation and generation.
D. Urry (1998)
Osmolyte-mediated encapsulation of proteins inside MS2 viral capsids.
J. Glasgow (2012)
Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation.
Nicholas M. Molino (2013)
Fabrication of novel biomaterials through molecular self-assembly
S. Zhang (2003)
Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth
U. Kar (2011)
Building better drugs: developing and regulating engineered therapeutic proteins.
C. Kimchi-Sarfaty (2013)
Colorful virus-like particles: fluorescent protein packaging by the Qβ capsid.
Jin-Kyu Rhee (2011)
Immunogenicity of protein aggregates--concerns and realities.
W. Wang (2012)
Self-assembly and aggregation of proteins
E. Linden (2007)
Effect of polymer amphiphilicity on loading of a therapeutic enzyme into protective filamentous and spherical polymer nanocarriers.
Eric A Simone (2007)
Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics.
Satoshi Nagata (2009)
Lentivirus-based virus-like particles as a new protein delivery tool.
C. Muratori (2010)
Enzyme delivery using the 30Kc19 protein and human serum albumin nanoparticles.
Hong Jai Lee (2014)
Lumazine synthase protein cage nanoparticles as antigen delivery nanoplatforms for dendritic cell-based vaccine development
Jae-Sun Ra (2014)
Delivery of therapeutic proteins.
D. Pisal (2010)
Protein oligomerization: how and why.
M. H. Ali (2005)
Immunological properties of engineered nanomaterials
M. Dobrovolskaia (2007)
Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery
M. L. Tan (2010)
A peptide carrier for the delivery of biologically active proteins into mammalian cells
M. Morris (2001)
Virus-Like Particles Harboring CCL19, IL-2 and HPV16 E7 Elicit Protective T Cell Responses in HLA-A2 Transgenic Mice
V. Juárez (2012)
Concentrated dispersions of equilibrium protein nanoclusters that reversibly dissociate into active monomers.
Keith P. Johnston (2012)
Carbon nanotubes: biomaterial applications.
N. Saito (2009)
Impact of nanotechnology on drug delivery.
O. Farokhzad (2009)
Engineering of vault nanocapsules with enzymatic and fluorescent properties.
V. Kickhoefer (2005)
Non-amyloidogenic peptide tags for the regulatable self-assembling of protein-only nanoparticles.
U. Unzueta (2012)
Designed nanocage displaying ligand-specific Peptide bunches for high affinity and biological activity.
J. O. Jeon (2013)
Rational design of self-assembled proteins and peptides for nano- and micro-sized architectures
Kazunori Matsuurua (2014)
Adaptations of nanoscale viruses and other protein cages for medical applications.
L. A. Lee (2006)
Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
N. Kushnir (2012)
Effects of Hofmeister anions on the phase transition temperature of elastin-like polypeptides.
Y. Cho (2008)
A peptide-based carrier for intracellular delivery of proteins into malignant glial cells in vitro.
C. Wu (2008)
A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity
C. Champion (2009)
Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform.
H. Kang (2012)
PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.
Laetitia Kurzawa (2010)
Intracellular targeting of CD44+ cells with self-assembling, protein only nanoparticles.
Mireia Pesarrodona (2014)
Alveolar wall apoptosis causes lung destruction and emphysematous changes.
K. Aoshiba (2003)
Caged protein nanoparticles for drug delivery.
Nicholas M. Molino (2014)
Tailoring nanocarriers for intracellular protein delivery.
Z. Gu (2011)
Desolvation process and surface characterisation of protein nanoparticles.
C. Weber (2000)
Highly efficient delivery of p16 antitumor peptide into aggressive leukemia/lymphoma cells using a novel transporter system.
E. Kondo (2004)
Self-assembly of peptides into spherical nanoparticles for delivery of hydrophilic moieties to the cytosol.
L. Collins (2010)
Thermoresponsive self-assembled elastin-based nanoparticles for delivery of BMPs.
Paulo C. Bessa (2010)
Self-Assembly in the Ferritin Nano-Cage Protein Superfamily
Y. Zhang (2011)
Multifunctional materials through modular protein engineering.
Rebecca L DiMarco (2012)
Engineered mutations change the structure and stability of a virus-like particle.
Jason D. Fiedler (2012)
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
F. Kratz (2008)
Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
K. Langer (2003)
Temperature of polypeptide inverse temperature transition depends on mean residue hydrophobicity
D. W. Urry (1991)
In vivo architectonic stability of fully de novo designed protein-only nanoparticles.
María Virtudes Céspedes (2014)
RNA-directed packaging of enzymes within virus-like particles.
Jason D. Fiedler (2010)
Radio-synthesized protein-based nanoparticles for biomedical purposes
Gustavo H.C. Varca (2014)
Albumin-based nanoparticles as potential controlled release drug delivery systems.
Ahmed O Elzoghby (2012)
Cell Targeting with Hybrid Qβ Virus‐Like Particles Displaying Epidermal Growth Factor
J. Pokorski (2011)
Recombinant spider silk particles for controlled delivery of protein drugs.
M. Hofer (2012)
A virus-based single-enzyme nanoreactor.
Marta Comellas-Aragonès (2007)
Controlled Apoptosis by a Thermally Toggled Nanoscale Amplifier of Cellular Uptake
Sarah R MacEwan (2014)
A quantitative recipe for engineering protein polymer nanoparticles.
S. M. Janib (2014)
Stimuli-responsive nanomaterials for therapeutic protein delivery.
Y. Lu (2014)
Laboratory evolution of copper tolerant yeast strains
G. M. Adamo (2012)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
M. Bachmann (2010)
Gramicidin A-based peptide vector for intracellular protein delivery.
Tatiana B Stoilova (2008)
Preparation of BMP-2 Containing Bovine Serum Albumin (BSA) Nanoparticles Stabilized by Polymer Coating
G. Wang (2008)
Silk fibroin nanoparticles for cellular uptake and control release.
J. Kundu (2010)
Accurate design of co-assembling multi-component protein nanomaterials
N. King (2014)
Protein delivery using engineered virus-like particles
S. J. Kaczmarczyk (2011)
Protein nanoparticles for intracellular delivery of therapeutic enzymes.
L. H. Estrada (2014)
Physical mechanisms and biological significance of supramolecular protein self-assembly.
A. Kentsis (2004)
Vault particles: a new generation of delivery nanodevices.
A. Casañas (2012)
Virus-like particle-based human vaccines: quality assessment based on structural and functional properties.
Qinjian Zhao (2013)
Intracellular Protein Delivery Systems Formed by Noncovalent Bonding Interactions between Amphipathic Peptide Carriers and Protein Cargos.
S. L. Lo (2010)
Two-step protein self-assembly in the extracellular matrix.
W. M. Park (2013)
Engineered M13 bacteriophage nanocarriers for intracellular delivery of exogenous proteins to human prostate cancer cells.
Sandra M. DePorter (2014)
Protein-based nanocarriers as promising drug and gene delivery systems.
Ahmed O Elzoghby (2012)
Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.
R. Zhang (2010)
Vault nanoparticles containing an adenovirus-derived membrane lytic protein facilitate toxin and gene transfer.
Cheng-Yu Lai (2009)
Nanoreactors by programmed enzyme encapsulation inside the capsid of the bacteriophage P22.
Dustin P Patterson (2012)
The ferritin superfamily: Supramolecular templates for materials synthesis.
M. Uchida (2010)
Quantification of the effects of chain length and concentration on the thermal behavior of elastin-like polypeptides.
D. E. Meyer (2004)
Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development.
Jae-A Han (2014)
Formulations for delivery of therapeutic proteins
S. Stolnik (2008)
Epidermal growth factor-ferritin H-chain protein nanoparticles for tumor active targeting.
X. Li (2012)
Inorganic nanomaterials as delivery systems for proteins, peptides, DNA, and siRNA
M. Malmsten (2013)
Construction and Characterization of Virus-Like Particles: A Review
Andris Zeltiņš (2012)
Peptide therapeutics: targeting the undruggable space.
N. Tsomaia (2015)
Applications of elastin-like polypeptides in drug delivery.
Sarah R MacEwan (2014)
Stability of Protein Pharmaceuticals
M. Manning (2004)
PKA delivery to the distal lung air spaces increases alveolar liquid clearance after isoproterenol-induced alveolar epithelial PKA desensitization.
M. B. Maron (2005)
A library of protein cage architectures as nanomaterials.
M. Flenniken (2009)
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.
S. Balthasar (2005)
Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines.
Li Wang (2014)
Protein-based nanomedicine platforms for drug delivery.
A. Maham (2009)
Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines
E. Kondo (2008)
Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cells.
W. Wang (2014)
Polyethylenimine‐coated albumin nanoparticles for BMP‐2 delivery
S. Zhang (2008)
Vault nanoparticles engineered with the protein transduction domain, TAT48, enhances cellular uptake.
J. Yang (2013)
Intracellular delivery of protein and peptide therapeutics.
V. Torchilin (2008)
Melanoma and lymphocyte cell-specific targeting incorporated into a heat shock protein cage architecture.
M. Flenniken (2006)
Directed Evolution of a Protein Container
Bigna Wörsdörfer (2011)
Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds
Piyush Koria (2010)
Targeting vault nanoparticles to specific cell surface receptors.
V. Kickhoefer (2009)
This paper is referenced by
Emerging methods in therapeutics using multifunctional nanoparticles.
Nahal Habibi (2020)
Effects of ovalbumin protein nanoparticle vaccine size and coating on dendritic cell processing.
Timothy Z. Chang (2017)
Hepatitis E Nanoparticle: A Capsid-Based Platform for Non-Invasive Vaccine Delivery and Imaging-Guided Cancer Treatment
R. Holland Cheng (2018)
Programed Assembly of Nucleoprotein Nanoparticles Using DNA and Zinc Fingers for Targeted Protein Delivery.
Yiseul Ryu (2018)
Biopolymers in Regenerative Medicine: Overview, Current Advances and Future Trends
J. Ruso (2016)
Bio‐nano interface: The impact of biological environment on nanomaterials and their delivery properties
Kaimin Cai (2017)
The role of surface charge in the desolvation process of gelatin: implications in nanoparticle synthesis and modulation of drug release
Saad M Ahsan (2017)
Functional characterizations of interactive recombinant PTEN–silica nanoparticles for potential biomedical applications
N. Arora (2016)
Specific Internalisation of Gold Nanoparticles into Engineered Porous Protein Cages via Affinity Binding
David Paramelle (2016)
Effect of structure in ionised albumin based nanoparticle: Characterisation, Emodin interaction, and in vitro cytotoxicity.
M. Siri (2019)
Nanoparticles and Their Applications
S. Moeinzadeh (2017)
The role of intermolecular interactions on the encapsulation of human insulin into the chitosan and cholesterol-grafted chitosan polymers.
Safoura Salar (2019)
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Abuzer Alp Yetisgin (2020)
Electrochemical behavior of ferritin at the polarized water|1,2-dichloroethane interface
Hiroki Sakae (2018)
Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics
Na Kyeong Lee (2017)
Effect of structure in ionized albumin – based nanoparticle: Characterisation, Emodin interaction, and in vitro cytotoxicity
Macarena Siri (2019)
Nanocapsules of therapeutic proteins with enhanced stability and long blood circulation for hyperuricemia management
X. Zhang (2017)
Nanoscale cationic micelles of amphiphilic copolymers based on star-shaped PLGA and PEI cross-linked PEG for protein delivery application
Jun Wang (2019)
Tumor-specific disintegratable nanohybrids containing ultrasmall inorganic nanoparticles: from design and improved properties to cancer applications
Y. Wang (2018)
Rational Design of Nanocarriers for Intracellular Protein Delivery.
Xiaofei Qin (2019)
Delivering Proapoptotic Peptide by HSP Nanocage for Cancer Therapy
Dongmei Wang (2020)
Harnessing the layer-by-layer assembly technique to design biomaterials vaccines for immune modulation in translational applications.
Tan Tang (2019)
Overcoming T. gondii infection and intracellular protein nanocapsules as biomaterials for ultrasonically controlled drug release.
M. Aw (2017)
Self-assembled hybrid supraparticles that proteolytically degrade tumor necrosis factor-α.
W. M. Park (2016)
Understanding the Interplay between Self-Assembling Peptides and Solution Ions for Tunable Protein Nanoparticle Formation.
Bhuvana Kamath Shanbhag (2018)
Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes
Talar Tokatlian (2018)
Nanotechnology: Nanomedicine, Nanotoxicity and Future Challenges
V. Kumar (2018)
Protein Nanoparticle Formation Using a Circularly Permuted α-Helix-Rich Trimeric Protein.
Norifumi Kawakami (2017)
Multifunctional and Redox-Responsive Self-Assembled Magnetic Nanovectors for Protein Delivery and Dual-Modal Imaging.
H. Y. Yang (2017)
Designed trimer-mimetic TNF superfamily ligands on self-assembling nanocages.
Minwoo Kih (2018)
Biodegradable Magnetic Silica@Iron Oxide Nanovectors with Ultra‐Large Mesopores for High Protein Loading, Magnetothermal Release, and Delivery
Haneen Omar (2017)
Self-assembly of collagen-based biomaterials: preparation, characterizations and biomedical applications.
Shichen Zhu (2018)See more